Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: A rapid test for reversibility of pulmonary hypertension

Journal of the American College of Cardiology

Volumn 28, Issue 7, 1997, Pages 1775-1780

  Givertz, Michael M ^b   Hare, Joshua M ^b   Loh, Evan ^b   Gauthier, Diane F ^b   Colucci, Wilson S ^a  

^a BOSTON MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MILRINONE; PHOSPHODIESTERASE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG VASCULAR RESISTANCE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ADULT; AGED; CARDIAC OUTPUT; FEMALE; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PULMONARY; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MILRINONE; PULMONARY ARTERY; PULMONARY WEDGE PRESSURE; PYRIDONES; VASCULAR RESISTANCE; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0030450363     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00399-3     Document Type: Article

References (34)

1. Costard-Jäckle A, Hill I, Schroeder JS, Fowler MB. The influence of preoperative patient characteristics on early and late survival following cardiac transplantation. Circulation 1991;84 Suppl III:III-329-37.
2. Loh E, Colucci WS, Mudge GH. Cardiac transplantation in the 1990s. Cardiol Rev 1993;1:218-27.
3. Murali S, Kormos RL, Uretsky BF, et al. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. Am Heart J 1993;126:896-904.
4. Addonizio LJ, Gersony WM, Robbins RC, et al. Elevated pulmonary vascular resistance and cardiac transplantation. Circulation 1987;76 Suppl V:V-52-5.
5. Kirklin JK, Naftel DC, Kirklin JW, Blackstone EH, White-Williams C, Bourge RC. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant 1988;7:331-6.
6. Costard-Jäckle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 1992;19:48-54.
7. Murali S, Uretsky BF, Armitage JM, et al. Utility of prostaglandin El in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension. J Heart Lung Transplant 1992;11:716-23.
8. Haywood GA, Sneddon JF, Bashir Y, Jennison SH, Gray HH, McKenna WJ. Adenosine infusion for the reversal of pulmonary vasoconstriction in biventricular failure: a good test but a poor therapy. Circulation 1992;86:896-902.
9. Loh E, Stamler JS, Hare JM, Loscalzo J, Colucci WS. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation 1994;90:2780-5.
10. Semigran MJ, Cockrill BA, Kacmarek R, et al. Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol 1994;24:982-8.
11. Kieler-Jensen N, Ricksten SE, Stenqvist O, et al. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. J Heart Lung Transplant 1994;13:366-75.
12. Adatia I, Perry S, Landzberg M, Moore P, Thompson JE, Wessel DL. Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation. J Am Coll Cardiol 1995;25:1656-64.
13. Ludmer PL, Wright RF, Arnold JM, Ganz P, Braunwald E, Colucci WS. Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique. Circulation 1986;73:130-7.
14. Cody RJ, Muller FB, Kubo SH, Rutman H, Leonard D. Identification of the direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failure. Circulation 1986;73:124-9.
15. Jaski BE, Fifer MA, Wright RF, Braunwald E, Colucci WS. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure: dose-response relationships and comparison to nitroprusside. J Clin Invest 1985;75:643-9.
16. Bairn DS, McDowell AV, Cherniles J, et al. Evaluation of a new bipyridine inotropic agent - milrinone - in patients with severe congestive heart failure. N Engl J Med 1983;309:748-56.
17. LeJemtel TH, Maskins CS, Mancini D, Sinoway L, Feld H, Chadwick B. Systemic and regional hemodynamic effects of captopril and milrinone administered alone and concomitantly in patients with heart failure. Circulation 1985;72:364-9.
18. Colucci WS, Wright RF, Braunwald E. New positive inotropic agents in the treatment of heart failure: mechanism of action and recent clinical development (second of two parts). N Engl J Med 1986;314:349-58.
19. Alousi AA, Johnson DC. Pharmacology of the bipyridines: amrinone and milrinone. Circulation 1986;73 Suppl III:III-10-24.
20. Kauffman RF, Schenck KW, Utterback BG, Crowe VG, Cohen ML. In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides. J Pharmacol Exp Ther 1987;242:864-72.
21. Rossing TH, Drazen JM. Effects of milrinone on contractile responses of guinea pig trachea, lung parenchyma and pulmonary artery. J Pharmacol Exp Ther 1986;238:874-9.
22. Mathew R, Wang J, Gewitz MH, Hintze TH, Wolin MS. Congestive heart failure alters receptor-dependent cAMP-mediated relaxation of canine pulmonary arteries. Circulation 1993;87:1722-8.
23. Leier CV, Bambach D, Thompson MJ, Cattaneo SM, Goldberg RJ, Unverforth DV. Central and regional hemodynamic effects of intravenous isosorbide dinatrate, nitroglycerin, and nitroprusside in patients with congestive heart failure. Am J Cardiol 1981;48:1115-23.
24. Monrad ES, Baim DS, Smith HS, Lanoue AS. Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure. Circulation 1986;73 Suppl III:III-168-74.
25. Harris P, Segel N, Bishop JM. The relation between pressure and flow in the pulmonary circulation in normal subjects and in patients with chronic bronchitis and mitral stenosis. Cardiovasc Res 1968;2:73-83.
26. Drexler H, Zeiher AM, Wollschlager H, Meinertz T, Just H, Bonzel T. Flow-dependent coronary artery dilatation in humans. Circulation 1989;80:466-74.
27. Linehan JH, Dawson CA. Pulmonary vascular resistance (P:Q relations). In: Fishman AP, editor. The Pulmonary Circulation: Normal and Abnormal Mechanisms, Management, and the National Registry. Philadelphia: Univ. of Pennsylvania Press, 1990:41-55.
28. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 1986;250:H1145-49.
29. Cooke JP, Stamler J, Andon N, Davies PF, McKinley G, Loscalzo J. Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. Am J Physiol 1990;259:H804-12.
30. Joannides R, Haefeli WE, Linder L, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995;91:1314-9.
31. Coddens J, Delooft T, Vandenbroucke G. Effects of dobutamine and/or nitroprusside on the pulmonary circulation in patients with pulmonary hypertension secondary to end-stage heart failure. J Cardiothorac Vasc Anesth 1993;7:321-5.
32. Kirklin JK, Naftel DC, McGiffin DC, McVay RF, Blackstone EH, Karp RB. Analysis of morbid events and risk factors for death after cardiac transplantation. J Am Coll Cardiol 1988;11:917-24.
33. Mudge GH, Goldstein S, Addonizio LJ, et al. 24th Bethesda Conference: cardiac transplantation. J Am Coll Cardiol 1993;22:21-31.
34. Brecker SJ, Xiao HB, Mbaissouroum M, Gibson DG. Effects of intravenous milrinone on left ventricular function in ischemic and idiopathic dilated cardiomyopathy. Am J Cardiol 1993;71:203-9.